Telix Pharmaceuticals Limited (ASX:TLX) Completes Acquisition of FAP-targeting Theranostic Candidates
Telix Pharmaceuticals (ASX:TLX) completes acquisition of FAP-targeting theranostic candidates, expanding its oncology pipeline.
Category: Healthcare
PolyNovo Limited (ASX:PNV) Announces Change of CEO
PolyNovo Limited (ASX:PNV) announces CEO transition with Dr Robyn Elliott appointed as Acting CEO as it seeks a permanent successor.
4DMedical Limited (ASX:4DX) Announces 3-Year Contract Renewal with Cleveland Clinic
4DMedical Limited (ASX:4DX) secures a 3-year contract extension with Cleveland Clinic, ensuring continued revenue growth and expanding its presence in respiratory imaging.
Echo IQ (ASX:EIQ) Announces Upcoming Investor Webinar
Echo IQ (ASX:EIQ) announces an investor webinar to discuss its US commercialisation strategy and clinical pipeline.
333D Limited (ASX:T3D) Appoints John Conidi as CEO and Managing Director
333D Limited (ASX:T3D) appoints John Conidi as CEO, highlighting increased revenue and strategic investment in digital asset management.
Spacetalk Ltd (ASX:SPA) Licenses Watch Walk AI for Health Risk Detection
Spacetalk Ltd (ASX:SPA) licenses Watch Walk AI to enhance health risk detection in its wearable devices.
Fisher & Paykel Healthcare (ASX:FPH) Signs NZ$250M Construction Contract for Auckland Campus
Fisher & Paykel Healthcare (ASX:FPH) signs a $250M construction contract to expand its Auckland campus, enhancing capacity for future growth.
Wellnex Life Limited (ASX:WNX) Raises $2.2M Through Entitlement Offer
Wellnex Life Limited (ASX:WNX) raises $2.2 million through Entitlement Offer and moves forward with dual AIM listing.
Race Oncology (ASX:RAC) Executes $8.6m Contract for Phase 1 RC220 Trial
Race Oncology (ASX:RAC) secures an $8.6m contract with George Clinical to advance Phase 1 trials of RC220 in solid tumour patients.
Oceania Healthcare (ASX:OCA) Reports FY25 Market Update and Refinancing
Oceania Healthcare (ASX:OCA) reports increased sales, successful $500m debt refinancing, and strategic business optimisations for FY25.